These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23264557)

  • 1. A cure rate survival model under a hybrid latent activation scheme.
    Borges P; Rodrigues J; Louzada F; Balakrishnan N
    Stat Methods Med Res; 2016 Apr; 25(2):838-56. PubMed ID: 23264557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expectation maximization-based likelihood inference for flexible cure rate models with Weibull lifetimes.
    Balakrishnan N; Pal S
    Stat Methods Med Res; 2016 Aug; 25(4):1535-63. PubMed ID: 23740876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new cure rate model with flexible competing causes with applications to melanoma and transplantation data.
    Leão J; Bourguignon M; Gallardo DI; Rocha R; Tomazella V
    Stat Med; 2020 Oct; 39(24):3272-3284. PubMed ID: 32716081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.
    Balakrishnan N; Barui S; Milienos FS
    Stat Methods Med Res; 2017 Oct; 26(5):2055-2077. PubMed ID: 28523958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The destructive negative binomial cure rate model with a latent activation scheme.
    Cancho VG; Bandyopadhyay D; Louzada F; Yiqi B
    Stat Methodol; 2013 Jul; 13():48-68. PubMed ID: 23585760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the use of the modified power series family of distributions in a cure rate model context.
    Gallardo DI; Gómez YM; Gómez HW; de Castro M
    Stat Methods Med Res; 2020 Jul; 29(7):1831-1845. PubMed ID: 31559906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expectation Maximization Algorithm for Box-Cox Transformation Cure Rate Model and Assessment of Model Misspecification Under Weibull Lifetimes.
    Pal S; Balakrishnan N
    IEEE J Biomed Health Inform; 2018 May; 22(3):926-934. PubMed ID: 28534799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distribution of tumor size at detection: an application to breast cancer data.
    Tsodikov AD; Asselain B; Yakovlev AY
    Biometrics; 1997 Dec; 53(4):1495-502. PubMed ID: 9423264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On a class of non-linear transformation cure rate models.
    Balakrishnan N; Milienos FS
    Biom J; 2020 Sep; 62(5):1208-1222. PubMed ID: 32175632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian destructive weighted Poisson cure rate model and an application to a cutaneous melanoma data.
    Rodrigues J; Cancho VG; de Castro M; Balakrishnan N
    Stat Methods Med Res; 2012 Dec; 21(6):585-97. PubMed ID: 21131689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival.
    Eloranta S; Lambert PC; Andersson TM; Björkholm M; Dickman PW
    Epidemiology; 2014 Sep; 25(5):742-8. PubMed ID: 25036430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new long-term survival model with dispersion induced by discrete frailty.
    Cancho VG; Macera MAC; Suzuki AK; Louzada F; Zavaleta KEC
    Lifetime Data Anal; 2020 Apr; 26(2):221-244. PubMed ID: 30968271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The exponential-Poisson model for recurrent event data: an application to a set of data on malaria in Brazil.
    Macera MA; Louzada F; Cancho VG; Fontes CJ
    Biom J; 2015 Mar; 57(2):201-14. PubMed ID: 25346061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified stochastic EM algorithm for cure rate model with negative binomial competing risks: An application to breast cancer data.
    Pal S
    Stat Med; 2021 Dec; 40(28):6387-6409. PubMed ID: 34783093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general class of promotion time cure rate models with a new biological interpretation.
    Gómez YM; Gallardo DI; Bourguignon M; Bertolli E; Calsavara VF
    Lifetime Data Anal; 2023 Jan; 29(1):66-86. PubMed ID: 36114312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A power series beta Weibull regression model for predicting breast carcinoma.
    Ortega EM; Cordeiro GM; Campelo AK; Kattan MW; Cancho VG
    Stat Med; 2015 Apr; 34(8):1366-88. PubMed ID: 25620602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.